We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ‘Skinny Labeling’ of Generics Threatened by Appeals Court Ruling, Academics Argue
The item has been added to your shopping cart.
‘Skinny Labeling’ of Generics Threatened by Appeals Court Ruling, Academics Argue
A federal appeals court ruling last year against Teva Pharmaceuticals threatens other generic drugmakers, according to an amicus brief filed Dec. 22 by a roll call of professors of law, economics, business, health and medicine.